6-alpha-methyl-progesterone is a synthetic progestin, a type of steroid hormone, that is structurally similar to progesterone. It is a potent progestational agent and has been studied for its potential therapeutic uses in a variety of conditions. It was initially synthesized as a potential contraceptive agent, but has also been investigated for its effects on endometriosis, uterine fibroids, and breast cancer. It is not currently approved for any therapeutic use in the United States. Research into 6-alpha-methyl-progesterone focuses on its potential applications in various medical fields and its mechanism of action. It is studied to understand its effects on the body and to determine its safety and efficacy in specific therapeutic settings.'
6-alpha-methyl-progesterone: a synthetic derivative of PROGESTERONE; with anti-androgenic & synandrogenic activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 92847 |
| CHEBI ID | 34476 |
| SCHEMBL ID | 7978305 |
| MeSH ID | M0074083 |
| Synonym |
|---|
| pregn-4-ene-3, 6.alpha.-methyl- |
| 903-71-9 |
| pregn-4-ene-3, 6-methyl-, (6.alpha.)- |
| nsc-75530 |
| nsc75530 |
| 6.alpha.-methylprogesterone |
| 6-alpha-methylprogesterone |
| (6alpha)-6-methylpregn-4-ene-3,20-dione |
| (6-alpha)-6-methylpregn-4-ene-3,20-dione |
| pregn-4-ene-3,20-dione, 6alpha-methyl- |
| pregn-4-ene-3,20-dione, 6-methyl-, (6-alpha)- |
| nsc 75530 |
| 6-alpha-methylpregn-3-ene-3,20-dione |
| pregn-4-ene-3,20-dione, 6-methyl-, (6alpha)- |
| pregn-4-ene-3,20-dione, 6-alpha-methyl- |
| 6alpha-methylprogesterone |
| 6alpha-methylpregn-4-ene-3,20-dione |
| 6-alpha-methyl-progesterone |
| unii-ykt998y6uz |
| ykt998y6uz , |
| methylprogesterone, 6.alpha. |
| pregn-4-ene-3,20-dione,6.alpha.-methyl- |
| SCHEMBL7978305 |
| 6a-methyl-4-pregnene-3 ,20-dione |
| CHEBI:34476 |
| pregn-4-ene-3,20-dione, 6-methyl-, (6.alpha.)- |
| pregn-4-ene-3,20-dione, 6.alpha.-methyl- |
| 6-.alpha.-methylpregn-3-ene-3,20-dione |
| GNFABWAPJFOZSF-KTORGGLSSA-N |
| Q27116095 |
| DTXSID601294866 |
| Class | Description |
|---|---|
| corticosteroid hormone | Any of a class of steroid hormones that are produced in the adrenal cortex. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||